Antongiulio Faggiano

Pubblicazioni

Titolo Pubblicato in Anno
Correction to. Multiple endocrine neoplasia type 1. analysis of germline MEN1 mutations in the Italian multicenter MEN1 patient database ENDOCRINE 2018
Neuroendocrine Tumors in Real Life 2018
Circulating tumor cells and miRNAs as prognostic markers in neuroendocrine neoplasms ENDOCRINE-RELATED CANCER 2017
Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 2017
Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database ENDOCRINE 2017
The management of neuroendocrine tumours: a nutritional viewpoint CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION 2017
Natural history of localized and locally advanced lung atypical carcinoid after complete resection: a joined french-italian multicentric retrospective study NEUROENDOCRINOLOGY 2017
Accuracy of Fine Needle Cytology in Histological Prediction of Papillary Thyroid Carcinoma Variants: a Prospective Study ENDOCRINE PATHOLOGY 2017
The safety of available treatments options for neuroendocrine tumors EXPERT OPINION ON DRUG SAFETY 2017
Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: a multicenter study EUROPEAN JOURNAL OF ENDOCRINOLOGY 2017
Role of contrast-enhanced ultrasound to define prognosis and predict response to biotherapy in pancreatic neuroendocrine tumors JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2017
Risk factors of type 1 gastric neuroendocrine neoplasia in patients with chronic atrophic gastritis. A retrospective, multicentre study ENDOCRINE 2017
Animal models of medullary thyroid cancer: state of the art and view to the future ENDOCRINE-RELATED CANCER 2017
Unintentional recurrent laryngeal nerve injuries following thyroidectomy. Is it the surgeon who pays the bill? INTERNATIONAL JOURNAL OF SURGERY 2017
Effects of the single and combined treatment with dopamine agonist, somatostatin analog and mTOR inhibitors in a human lung carcinoid cell line. an in vitro study ENDOCRINE 2017
Germline polymorphisms of the VEGF pathway predict recurrence in nonadvanced differentiated thyroid cancer THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 2017
Erratum to. Preliminary data of VEGF-A and VEGFR-2 polymorphisms as predictive factors of radiological response and clinical outcome in iodine-refractory differentiated thyroid cancer treated with sorafenib ENDOCRINE 2017
Loss of succinate dehydrogenase subunit B (SDHB) as a prognostic factor in advanced ileal well-differentiated neuroendocrine tumors ENDOCRINE 2017
Perinatal parenting stress, anxiety and depression outcome in first-time mothers and fathers: A three to six-months postpartum follow-up study. FRONTIERS IN PSYCHOLOGY 2016
Role of (68)Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1) ENDOCRINE 2016

ERC

  • LS2_1
  • LS2_14
  • LS4_4
  • LS4_9
  • LS4_12
  • LS7_4
  • LS7_8
  • LS7_10
  • LS7_14

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

La principale area di ricerca sono è l'endocrinologia oncologica con numerose pubblicazioni e progetti clinici e traslazionali sulle neoplasie neuroendocrine, le neoplasie tiroidee, l'iperparatiroidismo, i tumori ipofisari, i feocromocitomi e paragangliomi, le sindromi neoplastiche genetiche multiendocrine. In tale ambito l'interesse di ricerca va dagli studi epidemiologici e di valutazione di fattori prognostici clinici e molecolari, studi sul ruolo della sindrome metabolica, della nutrizione e dei fatoori ambientali sulle neoplasie endocrine e neuroendocrine, studi genetici (ricerca nuove mutazioni, VUS, screening genetico, analisi NGS), studi diagnostici sulla diagnosi biochimica e ormonale e la diagnosi di imaging, studi terapeutici sull'efficacia e tossicità di farmaci biologici come analoghi della somatostatina, dopamino-agonisti, inibitori di mTOR, inibitori tirosino-chinasici. Più di recente interesse per l'andrologia, i tumori testicolari e le malattie genetiche della sfera andrologica

Keywords

neuroendocrine tumors (NETs)
Neuroendocrine neoplasms
multiple endocrine neoplasia type 1
Multiple Endocrine Neoplasia Type 2a/drug therapy
medullary thyroid cancer
Hyperparathyroidism
endocrine disrupting chemicals
Endocrine Gland Neoplasms
Endocrine function
andrological health
Pheochromocytoma

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma